Bunge LimitedNYSE: BG
Consumer Staples · Agricultural Products & Services
$112.46
-3.17%
Vol: 1.4M
Research Digest
Friday, June 19, 2026
Bunge Global shares fell 3.3% around June 15 but remain up nearly 40% year-to-date on strong post-Viterra merger earnings momentum.
Bunge Global SA shares declined approximately 3.3% around June 15, 2026, to $123, though the stock retains a strong 39.7% year-to-date gain and 55.3% year-over-year return. The pullback follows the stock reaching an all-time high close of $131.41 on June 3, 2026. Q1 2026 results reported April 29 showed adjusted EPS of $1.83, and the company raised its full-year adjusted EPS outlook to $9.00-$9.50, up from $7.50-$8.00, driven by post-Viterra merger synergies and agribusiness consolidation benefits. Shareholders approved a $0.72 quarterly dividend at the May 20, 2026 AGM, paid June 1. Trailing free cash flow margin remains thin at 1.4%, and earnings per share have fallen 17% over three years, making valuation a key risk at current levels above 14.5x P/E. No new announcements in the past 48 hours.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Bunge shareholders approve increased $2.88 per share annual dividend at 2026 AGMPositive▶
On May 20, 2026, Bunge Global SA shareholders approved a cash dividend of $2.88 per share, payable in four equal installments of $0.72, at the 2026 Annual General Meeting in Geneva, an increase of $0.02 per share from last year. This follows strong Q1 2026 results that beat EPS estimates by over 100%, with Barclays raising its price target to $150 from $145. Bunge continues to integrate the acquired Viterra grain business and is executing land monetization. The dividend increase signals management confidence in cash flow and earnings stability post-merger. Risk remains around agribusiness commodity exposure and revenue softness despite EPS gains. Trading near recent highs around $124-$127.
May 20Bunge Global jumps to 52-week high near $132 on cooking oil tariff tailwinds despite Q1 net income declinePositive▶
Bunge Global SA rallied roughly 20% in recent trading amid U.S.-China cooking oil tariff cross-currents, with shares hitting a 52-week high near $131.95. Q1 2026 results showed sales jumping to $21.86 billion from $11.64B (post-Viterra merger) but net income fell to $68M from $201M and diluted EPS dropped to $0.35 from $1.48 — though adjusted EPS of $1.83 beat the $0.85 consensus. Management reaffirmed 2026 adjusted EPS guidance of $7.50-$8 with earnings weighted to H2. The board affirmed the quarterly dividend of $0.72 through early 2027 (a 2.26% yield, raised for six consecutive years). Management participated in the BMO Global Farm to Market Conference fireside chat on May 13. Analyst consensus is Strong Buy with average target of $132.29.
May 19Bunge Global trades near $124 on May 18, 2026 after a Q1 EPS beat ($1.83 vs. $0.87 est.) and a sharply raised 2026 EPS guide to $9.00-$9.50.Positive▶
Bunge Global shares traded between $120.83 and $125.06 on May 18, 2026 (closing near $124.56), holding most of the gains from a Q1 2026 print that delivered adjusted EPS of $1.83 versus a $0.87 consensus, even as revenue of $21.86B missed the ~$23.11B Street view. Management lifted full-year 2026 adjusted EPS guidance to $9.00-$9.50 from a prior $7.50-$8.00 range, framing post-Viterra integration as driving efficiency and profitability. The stock notched an all-time closing high of $130.38 on May 5. A May 13 fireside chat at the BMO Global Farm-to-Market conference reinforced the bullish narrative. The principal risk is grain-market volatility and continued revenue softness despite margin expansion.
May 18Bunge Q1 2026 EPS of $1.83 beat $0.89 estimate by ~106%; revenue surged to $21.86B from $11.64B post-Viterra mergerMixed▶
Bunge Global reported Q1 2026 results on May 13, with sales of $21.86B (up from $11.64B YoY) reflecting the Viterra merger, while net income fell to $68M from $201M and GAAP diluted EPS dropped to $0.35 from $1.48. Adjusted EPS came in at $1.83, beating the $0.89 estimate by 105.62%. The company is reshaping operations post-Viterra integration with strong Q1 adjusted earnings and an upgraded EPS outlook, though profitability faced margin headwinds. Management participated in a fireside chat at the BMO Global Farm to Market Conference on May 13. Shares traded between $121-124 in mid-May.
May 15Bunge Global Q1 2026 sales nearly doubled to $21.86B on Viterra merger but net income fell to $68M, with Barclays raising price target to $150.Mixed▶
Bunge Global reported Q1 2026 results on May 13, 2026: sales jumped to $21.86B from $11.64B YoY reflecting the Viterra merger, but net income fell to $68M from $201M and diluted EPS from continuing operations dropped to $0.35 from $1.48 due to integration costs and margin pressure. Management appeared at the BMO Global Farm to Market Conference on May 13. Recent analyst activity: J.P. Morgan and BMO Capital have Buy ratings (BMO initiated late April), Barclays raised PT to $150 from $145. Shares traded near $126 with 52-week range $71.64-$133.93. Risks remain on Viterra integration execution and oilseed crush margins.
May 14Bunge Global participated in BMO Global Farm to Market Conference May 13; FY26 EPS guide raised to $9.00-$9.50 after Viterra-merged Q1 resultsPositive▶
Bunge management participated in a fireside chat at the BMO Global Farm to Market Conference on May 13. Q1 2026 (reported April 29) showed sales surging to $21.86B from $11.64B YoY post-Viterra merger, with adjusted EPS of $1.83 and adjusted segment EBIT up 62.8% to $661M. Management raised FY26 adjusted EPS guidance to $9.00-$9.50 (from $7.50-$8.00) and FY26 capex to $1.5-$1.7B. Net income fell to $68M from $201M as integration and mix effects pressured GAAP profitability despite higher volumes. Barclays raised PT to $150 (from $145); Morgan Stanley and BMO maintained Buy ratings. Stock traded $124.52-$127.75 on May 13.
May 13Bunge reports Q1 2026 results May 13 with sales doubling to $21.86B post-Viterra, but net income falling to $68M as margin compression persists.Mixed▶
Bunge Global is reporting Q1 2026 results today (May 13) with sales rising to $21.86B from $11.64B YoY reflecting the Viterra integration, while net income fell to $68M from $201M and diluted continuing-ops EPS dropped to $0.35 from $1.48. Management is participating in a BMO Global Farm to Market Conference fireside chat today. The company previously raised FY26 adjusted EPS guidance to $9.00-$9.50 on April 29. Margin compression challenges the bullish narrative despite revenue strength. Barclays raised its PT to $150 in late April.
May 12Bunge Global is set to participate in the BMO Global Farm to Market Conference on May 13 after a Q1 EPS print of $1.83 and raising full-year guidance to $9.00-$9.50.Positive▶
Bunge Global's Q1 2026 adjusted EPS came in at $1.83, beating estimates of $0.89 by 105.62%, and management raised its full-year EPS guidance to $9.00-$9.50 despite inflation and geopolitical challenges. The company will participate in a fireside chat at the BMO Global Farm to Market Conference on May 13. Shares closed near $124.94, up roughly 33.6% year to date. JPMorgan reiterated a Buy and Barclays raised its target to $150 from $145. Sentiment is positive on continued post-Viterra merger execution.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| ADMARCHER | $75.01 | -1.95% | -3.2% | 14.2x | 0.60 | $36.2B |
| BGBUNGE | $112.46 | -3.17% | -6.1% | 10.3x | 0.62 | $21.8B |
| WMTWALMART | $117.25 | -0.75% | -10.4% | 35.6x | 0.60 | $932.5B |
| COSTCOSTCO | $952.10 | -1.40% | -11.4% | 42.0x | 0.87 | $421.9B |
| PGPROCTER | $151.06 | +0.33% | +5.6% | 21.2x | 0.39 | $350.2B |
| KOCOCA | $79.50 | -0.54% | -2.6% | 22.8x | 0.35 | $341.6B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price between 50d and 200d. Testing 50d support.